A detailed history of Ziegler Capital Management, LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Ziegler Capital Management, LLC holds 24,397 shares of DVAX stock, worth $308,866. This represents 0.01% of its overall portfolio holdings.

Number of Shares
24,397
Previous 21,452 13.73%
Holding current value
$308,866
Previous $299,000 1.0%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$11.7 - $14.98 $34,456 - $44,116
2,945 Added 13.73%
24,397 $302,000
Q3 2023

Oct 16, 2023

BUY
$12.64 - $14.99 $271,153 - $321,565
21,452 New
21,452 $316,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.6B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Ziegler Capital Management, LLC Portfolio

Follow Ziegler Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ziegler Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ziegler Capital Management, LLC with notifications on news.